Kishan Pandya
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Antineoplastic Combined Chemotherapy Protocols | 19 | 1982 | 121 |
Why?
| Breast Neoplasms | 20 | 1980 | 185 |
Why?
| Lung Neoplasms | 12 | 1986 | 159 |
Why?
| Hot Flashes | 4 | 2000 | 16 |
Why?
| Carcinoma, Non-Small-Cell Lung | 7 | 2000 | 23 |
Why?
| Cyclohexanecarboxylic Acids | 3 | 2004 | 24 |
Why?
| Amines | 3 | 2004 | 39 |
Why?
| gamma-Aminobutyric Acid | 3 | 2004 | 58 |
Why?
| Tamoxifen | 7 | 1994 | 38 |
Why?
| Taxoids | 2 | 2009 | 12 |
Why?
| Neoplasm Metastasis | 15 | 1980 | 112 |
Why?
| Neoplasms | 9 | 1988 | 239 |
Why?
| Colonic Neoplasms | 4 | 1986 | 63 |
Why?
| Antineoplastic Agents | 8 | 1982 | 190 |
Why?
| Pain | 4 | 1993 | 191 |
Why?
| Analgesics | 3 | 1993 | 47 |
Why?
| Carboplatin | 1 | 2009 | 16 |
Why?
| Imidazoles | 1 | 2009 | 47 |
Why?
| Middle Aged | 42 | 1980 | 1161 |
Why?
| Fluorouracil | 10 | 1986 | 49 |
Why?
| Diphosphonates | 1 | 2009 | 14 |
Why?
| Carcinoma, Small Cell | 1 | 2007 | 20 |
Why?
| Sirolimus | 1 | 2007 | 25 |
Why?
| Aged | 34 | 1982 | 988 |
Why?
| Protein Kinase Inhibitors | 1 | 2007 | 59 |
Why?
| Female | 47 | 1980 | 1643 |
Why?
| Neoplasm Recurrence, Local | 8 | 1980 | 118 |
Why?
| Radiation-Sensitizing Agents | 4 | 2001 | 29 |
Why?
| Menopause | 2 | 1993 | 27 |
Why?
| Aged, 80 and over | 13 | 1993 | 599 |
Why?
| Paclitaxel | 4 | 2001 | 37 |
Why?
| Cisplatin | 8 | 1986 | 43 |
Why?
| Antineoplastic Agents, Phytogenic | 4 | 2000 | 23 |
Why?
| Humans | 57 | 1980 | 1856 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2004 | 8 |
Why?
| Acetic Acids | 1 | 2004 | 31 |
Why?
| Adult | 32 | 1982 | 1317 |
Why?
| Treatment Outcome | 12 | 1993 | 661 |
Why?
| Drug Administration Schedule | 7 | 1998 | 191 |
Why?
| Endometrial Neoplasms | 1 | 2001 | 18 |
Why?
| Clonidine | 1 | 2000 | 24 |
Why?
| Adrenergic alpha-Agonists | 1 | 2000 | 24 |
Why?
| Postmenopause | 1 | 2000 | 27 |
Why?
| Male | 28 | 1980 | 1553 |
Why?
| Neoplasm Staging | 4 | 2007 | 125 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2000 | 30 |
Why?
| Drug Prescriptions | 2 | 1993 | 35 |
Why?
| Rectal Neoplasms | 3 | 1986 | 26 |
Why?
| Etoposide | 4 | 1995 | 37 |
Why?
| Appetite Stimulants | 1 | 1998 | 1 |
Why?
| Megestrol Acetate | 1 | 1998 | 1 |
Why?
| Remission Induction | 8 | 1989 | 64 |
Why?
| Survival Rate | 6 | 1998 | 250 |
Why?
| Carcinoma, Renal Cell | 1 | 1998 | 48 |
Why?
| Minority Groups | 1 | 1997 | 38 |
Why?
| Interferon-alpha | 1 | 1998 | 43 |
Why?
| Kidney Neoplasms | 1 | 1998 | 75 |
Why?
| Pilot Projects | 7 | 1985 | 264 |
Why?
| Ambulatory Care | 2 | 1994 | 106 |
Why?
| Follow-Up Studies | 8 | 1992 | 553 |
Why?
| Chemotherapy, Adjuvant | 2 | 1994 | 55 |
Why?
| Amenorrhea | 1 | 1994 | 13 |
Why?
| Double-Blind Method | 4 | 2000 | 274 |
Why?
| Nausea | 3 | 1980 | 34 |
Why?
| Cyclophosphamide | 5 | 1982 | 82 |
Why?
| Vomiting | 2 | 1992 | 45 |
Why?
| Palliative Care | 2 | 1989 | 65 |
Why?
| Administration, Oral | 3 | 2000 | 170 |
Why?
| Combined Modality Therapy | 5 | 1985 | 219 |
Why?
| Research Design | 2 | 1988 | 169 |
Why?
| Proportional Hazards Models | 3 | 2000 | 123 |
Why?
| Doxorubicin | 5 | 1995 | 60 |
Why?
| Pain Measurement | 2 | 1994 | 98 |
Why?
| Vincristine | 4 | 1982 | 27 |
Why?
| Survival Analysis | 7 | 1993 | 205 |
Why?
| Disease-Free Survival | 3 | 1994 | 102 |
Why?
| Canada | 2 | 1994 | 60 |
Why?
| Vitis | 1 | 2010 | 5 |
Why?
| Physician's Practice Patterns | 1 | 1993 | 149 |
Why?
| Beverages | 1 | 2010 | 19 |
Why?
| Hospitals, Community | 1 | 1990 | 51 |
Why?
| Questionnaires | 4 | 1993 | 360 |
Why?
| Mitomycin | 4 | 1986 | 13 |
Why?
| Adenocarcinoma | 4 | 1995 | 167 |
Why?
| Spiro Compounds | 1 | 1988 | 2 |
Why?
| Time Factors | 6 | 1980 | 896 |
Why?
| Fibroblast Growth Factor 7 | 1 | 2008 | 6 |
Why?
| Pneumonectomy | 1 | 2008 | 15 |
Why?
| Organometallic Compounds | 1 | 1988 | 40 |
Why?
| Antidepressive Agents | 1 | 2009 | 46 |
Why?
| Liver Neoplasms | 4 | 1980 | 97 |
Why?
| Camptothecin | 1 | 2007 | 6 |
Why?
| Health Status Indicators | 1 | 2008 | 66 |
Why?
| United States | 4 | 1988 | 604 |
Why?
| Head and Neck Neoplasms | 1 | 2008 | 47 |
Why?
| Drug Evaluation | 8 | 1980 | 54 |
Why?
| Drug Therapy, Combination | 4 | 1982 | 189 |
Why?
| Treatment Failure | 1 | 2007 | 88 |
Why?
| Infusions, Intravenous | 4 | 1989 | 87 |
Why?
| Neoplasms, Second Primary | 1 | 2008 | 31 |
Why?
| Carcinoma, Squamous Cell | 1 | 2008 | 111 |
Why?
| Placebos | 2 | 2000 | 110 |
Why?
| Patient Selection | 1 | 2007 | 155 |
Why?
| Vinblastine | 2 | 1986 | 22 |
Why?
| Procarbazine | 1 | 2004 | 6 |
Why?
| Disease Progression | 2 | 2000 | 244 |
Why?
| Severity of Illness Index | 2 | 2004 | 358 |
Why?
| Antimetabolites, Antineoplastic | 2 | 1998 | 29 |
Why?
| Thoracic Neoplasms | 1 | 2003 | 16 |
Why?
| Dysgerminoma | 1 | 1982 | 7 |
Why?
| Medical Oncology | 2 | 1992 | 28 |
Why?
| Mediastinal Neoplasms | 1 | 1982 | 21 |
Why?
| Prognosis | 4 | 1985 | 388 |
Why?
| Recombinant Proteins | 2 | 1998 | 290 |
Why?
| Megestrol | 1 | 2001 | 3 |
Why?
| Lymphatic Metastasis | 3 | 1994 | 77 |
Why?
| Oncologic Nursing | 2 | 1992 | 6 |
Why?
| Professional Staff Committees | 1 | 2001 | 6 |
Why?
| Radiation Oncology | 1 | 2001 | 11 |
Why?
| Hyperaldosteronism | 1 | 1980 | 5 |
Why?
| Patient Dropouts | 1 | 2000 | 24 |
Why?
| Thioguanine | 1 | 1980 | 5 |
Why?
| Quality-Adjusted Life Years | 1 | 2000 | 22 |
Why?
| Immunotherapy, Active | 1 | 1999 | 4 |
Why?
| Methotrexate | 4 | 1982 | 40 |
Why?
| Cancer Vaccines | 1 | 1999 | 21 |
Why?
| Age Factors | 2 | 1990 | 480 |
Why?
| Mitomycins | 3 | 1986 | 13 |
Why?
| Interleukin-1 | 1 | 1999 | 109 |
Why?
| Tomography, X-Ray Computed | 3 | 1982 | 321 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2003 | 85 |
Why?
| Stomach Neoplasms | 1 | 1995 | 28 |
Why?
| Menopause, Premature | 1 | 1994 | 2 |
Why?
| Prospective Studies | 2 | 1993 | 545 |
Why?
| Menstruation | 1 | 1994 | 10 |
Why?
| Ovariectomy | 1 | 1994 | 23 |
Why?
| Premenopause | 1 | 1994 | 16 |
Why?
| Randomized Controlled Trials as Topic | 2 | 1992 | 176 |
Why?
| Multicenter Studies as Topic | 1 | 1994 | 70 |
Why?
| Ovary | 1 | 1994 | 50 |
Why?
| Fluoxymesterone | 3 | 1997 | 1 |
Why?
| Drug Utilization | 1 | 1994 | 32 |
Why?
| Goserelin | 1 | 1993 | 5 |
Why?
| Occult Blood | 1 | 1993 | 8 |
Why?
| Health Services Needs and Demand | 1 | 1994 | 66 |
Why?
| Prostatic Neoplasms | 2 | 1989 | 120 |
Why?
| Psychology, Clinical | 1 | 1992 | 4 |
Why?
| Analgesics, Opioid | 1 | 1993 | 37 |
Why?
| Drug Therapy | 1 | 1992 | 38 |
Why?
| Education, Medical | 1 | 1993 | 79 |
Why?
| Regression Analysis | 1 | 1993 | 256 |
Why?
| Recurrence | 2 | 1997 | 261 |
Why?
| Mitosis | 2 | 2000 | 68 |
Why?
| Quality of Life | 2 | 1998 | 188 |
Why?
| Colorectal Neoplasms | 1 | 1993 | 55 |
Why?
| Drugs, Investigational | 1 | 1990 | 8 |
Why?
| Indazoles | 1 | 1990 | 5 |
Why?
| Behavior Therapy | 1 | 1992 | 51 |
Why?
| Tumor Stem Cell Assay | 1 | 2010 | 21 |
Why?
| Cell Cycle | 2 | 2001 | 121 |
Why?
| Dose Fractionation | 1 | 2010 | 25 |
Why?
| Translational Medical Research | 1 | 2010 | 20 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 1993 | 145 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 34 |
Why?
| Eating | 1 | 2010 | 37 |
Why?
| Retrospective Studies | 2 | 1985 | 653 |
Why?
| Bias (Epidemiology) | 1 | 1990 | 35 |
Why?
| Aminoglutethimide | 1 | 1989 | 3 |
Why?
| Tumor Cells, Cultured | 2 | 2001 | 233 |
Why?
| Flavonoids | 1 | 2010 | 46 |
Why?
| Sensitivity and Specificity | 2 | 1993 | 427 |
Why?
| Psychometrics | 1 | 2010 | 97 |
Why?
| Hydrocortisone | 1 | 1989 | 65 |
Why?
| Abdominal Neoplasms | 1 | 2008 | 20 |
Why?
| Mucositis | 1 | 2008 | 12 |
Why?
| Adenoma | 1 | 2008 | 46 |
Why?
| Self-Assessment | 1 | 2008 | 35 |
Why?
| Pituitary Neoplasms | 1 | 2008 | 25 |
Why?
| Carcinoid Tumor | 1 | 2008 | 20 |
Why?
| Glutamates | 1 | 2008 | 29 |
Why?
| Deoxycytidine | 1 | 2008 | 20 |
Why?
| Guanine | 1 | 2008 | 22 |
Why?
| Cell Line, Tumor | 1 | 2010 | 208 |
Why?
| Carcinoma | 1 | 1989 | 109 |
Why?
| Oxazoles | 1 | 1986 | 8 |
Why?
| Isoxazoles | 1 | 1986 | 15 |
Why?
| Clinical Trials as Topic | 2 | 1986 | 251 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1986 | 14 |
Why?
| Antibiotics, Antineoplastic | 1 | 1986 | 35 |
Why?
| Cytosine | 1 | 1986 | 20 |
Why?
| Chronic Disease | 1 | 2008 | 267 |
Why?
| Anthracenes | 1 | 1985 | 5 |
Why?
| Leukopenia | 1 | 1985 | 17 |
Why?
| Physicians | 1 | 1988 | 104 |
Why?
| Risk Factors | 2 | 1993 | 555 |
Why?
| New York | 1 | 1990 | 422 |
Why?
| Anthraquinones | 1 | 1984 | 4 |
Why?
| Hematologic Diseases | 2 | 1986 | 23 |
Why?
| Reproducibility of Results | 1 | 2008 | 391 |
Why?
| Glucocorticoids | 1 | 1986 | 107 |
Why?
| Mammary Neoplasms, Experimental | 1 | 1986 | 37 |
Why?
| Dose-Response Relationship, Drug | 1 | 2008 | 431 |
Why?
| Young Adult | 1 | 2008 | 380 |
Why?
| Lung Diseases | 1 | 1986 | 112 |
Why?
| Risk Assessment | 1 | 2008 | 324 |
Why?
| Maximum Tolerated Dose | 1 | 2003 | 18 |
Why?
| G2 Phase | 1 | 2003 | 20 |
Why?
| Diatrizoate | 1 | 1982 | 15 |
Why?
| Iodipamide | 1 | 1982 | 5 |
Why?
| Diatrizoate Meglumine | 1 | 1982 | 14 |
Why?
| Leucovorin | 1 | 1982 | 11 |
Why?
| Prednisone | 2 | 1986 | 80 |
Why?
| Cytarabine | 1 | 1982 | 32 |
Why?
| Burkitt Lymphoma | 1 | 1982 | 36 |
Why?
| Mesothelioma | 1 | 2001 | 22 |
Why?
| Radiotherapy Dosage | 1 | 2001 | 55 |
Why?
| Organizational Objectives | 1 | 2001 | 26 |
Why?
| Aldosterone Antagonists | 1 | 1980 | 6 |
Why?
| Aldosterone | 1 | 1980 | 14 |
Why?
| Spironolactone | 1 | 1980 | 9 |
Why?
| Ascites | 1 | 1980 | 14 |
Why?
| Diarrhea | 1 | 2000 | 41 |
Why?
| Axilla | 1 | 2000 | 16 |
Why?
| Likelihood Functions | 1 | 2000 | 43 |
Why?
| Serum Albumin | 1 | 1980 | 55 |
Why?
| Interprofessional Relations | 1 | 2001 | 58 |
Why?
| Alkaline Phosphatase | 1 | 1980 | 59 |
Why?
| Blood Cell Count | 1 | 1980 | 31 |
Why?
| Forecasting | 1 | 2001 | 147 |
Why?
| Bilirubin | 1 | 1980 | 29 |
Why?
| Cause of Death | 1 | 2000 | 82 |
Why?
| Hepatitis B Antibodies | 1 | 1999 | 11 |
Why?
| Edema | 1 | 1980 | 67 |
Why?
| Hodgkin Disease | 1 | 1982 | 46 |
Why?
| Lipid A | 1 | 1999 | 7 |
Why?
| Europe | 1 | 1999 | 54 |
Why?
| Mycobacterium | 1 | 1999 | 7 |
Why?
| Skin Tests | 1 | 1999 | 28 |
Why?
| Adolescent | 1 | 2008 | 891 |
Why?
| Receptors, Estrogen | 2 | 1984 | 44 |
Why?
| Mitolactol | 1 | 1998 | 2 |
Why?
| Adjuvants, Immunologic | 1 | 1999 | 73 |
Why?
| Flow Cytometry | 1 | 2000 | 216 |
Why?
| Mastectomy | 1 | 1997 | 26 |
Why?
| Cohort Studies | 1 | 2000 | 332 |
Why?
| Apoptosis | 1 | 2003 | 265 |
Why?
| Bone Neoplasms | 1 | 1998 | 83 |
Why?
| Follicle Stimulating Hormone | 1 | 1993 | 36 |
Why?
| Gonadal Steroid Hormones | 1 | 1993 | 30 |
Why?
| Reagent Kits, Diagnostic | 1 | 1993 | 16 |
Why?
| Attitude of Health Personnel | 1 | 1994 | 165 |
Why?
| Mass Screening | 1 | 1993 | 125 |
Why?
| Gastrointestinal Diseases | 1 | 1986 | 31 |
Why?
| Central Nervous System Diseases | 1 | 1986 | 33 |
Why?
| Respiratory Function Tests | 1 | 1986 | 72 |
Why?
| Interferons | 1 | 1986 | 39 |
Why?
| Organ Size | 1 | 1986 | 118 |
Why?
| Progesterone | 1 | 1986 | 42 |
Why?
| Mitoxantrone | 1 | 1984 | 9 |
Why?
| Rats, Inbred Strains | 1 | 1986 | 170 |
Why?
| Bone Marrow | 1 | 1986 | 109 |
Why?
| Rats | 1 | 1986 | 530 |
Why?
| Animals | 1 | 1986 | 1031 |
Why?
|
|
Pandya's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
